Back to search

Article

Mpox vaccine and infection-driven human immune signatures

2023-03-09

Abstract excerpt

<h4>Background</h4> Mpox (formerly known as monkeypox) outbreaks outside endemic areas peaked in July 2022, infecting > 85,000 people and raising concerns about our preparedness against this emerging viral pathogen. Licensed and approved for mpox, the JYNNEOS vaccine has fewer side effects than previous smallpox vaccines and demonstrated efficacy against mpox infection in humans. Comparing JYNNEOS vaccine- and mpo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e25f46b5-3fa8-5463-b37d-6a3731e1c575
DOI
10.1101/2023.03.07.23286701
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mpox vaccine and infection-driven human immune signaturesDOI 10.1101/2023.03.07.23286701
Select a neighboring publication to make it the new centre.